| Literature DB >> 25354781 |
Nathan R Campbell1, Scott E LaPatra2, Ken Overturf3, Richard Towner4, Shawn R Narum5.
Abstract
Recent advances in genotyping-by-sequencing have enabled genome-wide association studies in nonmodel species including those in aquaculture programs. As with other aquaculture species, rainbow trout and steelhead (Oncorhynchus mykiss) are susceptible to disease and outbreaks can lead to significant losses. Fish culturists have therefore been pursuing strategies to prevent losses to common pathogens such as Flavobacterium psychrophilum (the etiological agent for bacterial cold water disease [CWD]) and infectious hematopoietic necrosis virus (IHNV) by adjusting feed formulations, vaccine development, and selective breeding. However, discovery of genetic markers linked to disease resistance offers the potential to use marker-assisted selection to increase resistance and reduce outbreaks. For this study we sampled juvenile fish from 40 families from 2-yr classes that either survived or died after controlled exposure to either CWD or IHNV. Restriction site-associated DNA sequencing produced 4661 polymorphic single-nucleotide polymorphism loci after strict filtering. Genotypes from individual survivors and mortalities were then used to test for association between disease resistance and genotype at each locus using the program TASSEL. After we accounted for kinship and stratification of the samples, tests revealed 12 single-nucleotide polymorphism markers that were highly associated with resistance to CWD and 19 markers associated with resistance to IHNV. These markers are candidates for further investigation and are expected to be useful for marker assisted selection in future broodstock selection for various aquaculture programs.Entities:
Keywords: Flavobacterium psychrophilum; cold water disease; genetics of immunity; genotyping by sequencing; infectious hematopoietic necrosis virus
Mesh:
Substances:
Year: 2014 PMID: 25354781 PMCID: PMC4267942 DOI: 10.1534/g3.114.014621
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Families evaluated for disease resistance and chosen for inclusion in association testing
| Family ID | Disease Challenge | Year Class | Mortalities (Genotyped/Target) | Survivors (Genotyped/Target) | Mortality Rate |
|---|---|---|---|---|---|
| 08-130 | CWD | 2008 | 2/2 | 3/5 | 0.04 |
| 10-125 | CWD | 2010 | 0/3 | 3/5 | 0.06 |
| 08-121 | CWD | 2008 | 2/4 | 5/5 | 0.08 |
| 08-092 | CWD | 2008 | 5/5 | 5/5 | 0.12 |
| 08-073 | CWD | 2008 | 5/5 | 4/5 | 0.13 |
| 10-060 | CWD | 2010 | 5/5 | 5/5 | 0.14 |
| 10-078 | CWD | 2010 | 3/5 | 5/5 | 0.16 |
| 08-105 | CWD | 2008 | 5/5 | 5/5 | 0.28 |
| 10-028 | CWD | 2010 | 5/5 | 5/5 | 0.36 |
| 10-127 | CWD | 2010 | 5/5 | 0/5 | 0.61 |
| 10-101 | CWD | 2010 | 4/5 | 4/5 | 0.64 |
| 08-025 | CWD | 2008 | 3/5 | 5/5 | 0.65 |
| 10-094 | CWD | 2010 | 3/5 | 3/5 | 0.69 |
| 08-129 | CWD | 2008 | 1/5 | 4/5 | 0.70 |
| 08-082 | CWD | 2008 | 5/5 | 5/5 | 0.79 |
| 10-119 | CWD | 2010 | 5/5 | 4/5 | 0.80 |
| 08-075 | CWD | 2008 | 4/5 | 5/5 | 0.86 |
| 10-076 | CWD | 2010 | 4/5 | 5/5 | 0.89 |
| 10-068 | CWD | 2010 | 4/5 | 5/5 | 0.91 |
| 08-108 | CWD | 2008 | 5/5 | 4/4 | 0.91 |
| 10-059 | IHNV | 2010 | 1/2 | 5/5 | 0.04 |
| 10-053 | IHNV | 2010 | 3/5 | 5/5 | 0.10 |
| 08-113 | IHNV | 2008 | 0/2 | 5/5 | 0.17 |
| 10-015 | IHNV | 2010 | 4/5 | 5/5 | 0.26 |
| 10-007 | IHNV | 2010 | 5/5 | 3/5 | 0.27 |
| 08-094 | IHNV | 2008 | 5/5 | 5/5 | 0.27 |
| 08-117 | IHNV | 2008 | 5/5 | 5/5 | 0.28 |
| 10-001 | IHNV | 2010 | 5/5 | 5/5 | 0.29 |
| 08-008 | IHNV | 2008 | 3/5 | 4/5 | 0.33 |
| 08-043 | IHNV | 2008 | 1/5 | 1/5 | 0.33 |
| 08-110 | IHNV | 2008 | 5/5 | 5/5 | 0.33 |
| 10-050 | IHNV | 2010 | 5/5 | 5/5 | 0.75 |
| 08-093 | IHNV | 2008 | 5/5 | 4/5 | 0.80 |
| 10-067 | IHNV | 2010 | 5/5 | 5/5 | 0.83 |
| 10-023 | IHNV | 2010 | 5/5 | 4/4 | 0.91 |
| 08-107 | IHNV | 2008 | 5/5 | 3/4 | 0.91 |
| 10-021 | IHNV | 2010 | 5/5 | 4/4 | 0.92 |
| 08-039 | IHNV | 2008 | 4/5 | 1/3 | 0.94 |
| 08-018 | IHNV | 2008 | 1/5 | 0/3 | 0.94 |
| 10-124 | IHNV | 2010 | 5/5 | 2/2 | 0.96 |
Families are ordered by disease challenge and mortality rate. CWD, cold water disease; IHNV, infectious hematopoietic necrosis virus.
RAD markers showing significant association with disease resistance
| Marker | Association | LG | Marker Sequence | ||
|---|---|---|---|---|---|
| R45138 | CWD | 1.49E-05 | 1.78E-01 | WS08/Omy16 | TGGTCGCAAGGGGAAACATAGCCGCCATAGGCATCCTAAGCCTTTTAGGGC[T/A]GCAAAAC |
| R46743 | CWD | 5.31E-04 | 9.13E-03 | WS08/Omy16 | TTCATTCTCAACAACATCCAT[G/A]GAGTATGACCTTACCTCACAGAGGAAGCGGCGCAGGT |
| R26956 | CWD | 6.33E-04 | 1.23E-01 | WS23/Omy17 | GGAGGAAGAGAGGATGTGGGGGAGGAAGAGAGGATGTGGG[G/A]GAGGTTGGAAACATGATT |
| R46637 | CWD | 1.77E-03 | −5.24E-02 | WS05/Omy8 | CCTTGGTAGTGGGCCGTGTCGGTGGCACTG[T/C]ATTATCCTCAAAGCTGGTAAAGAAGGTG |
| R08795 | CWD | 1.91E-03 | 1.42E-01 | Omy29+ | CCACTTTCTGTCGCTCTCTTTGTCTCAGTCATTCCCTTTCTT[G/T]TGATTTCTTTCCCTTC |
| R13883 | CWD | 2.79E-03 | −1.43E-01 | WS13/Omy06 | TGCAGTTCTGAAGGTTGATTCAGCAGTATTTGGGGCATCGAAGTGATGGGACAT[A/G]TGAC |
| R49259 | CWD | 3.06E-03 | 1.49E-01 | NA | AAATCACGCACAGAACAAGC[A/T]GTACGGCTGGTGGTATTGTCATGCTTGAAGGTCATGTC |
| R34531 | CWD | 3.29E-03 | −5.92E-02 | WS13/Omy06 | TGATGCCCATGGCCTTGATCTTGGCCGA[T/C]TCGCTGCCCAGCTCGTTCAACTGCTGTTTA |
| R40622 | CWD | 3.52E-03 | 7.22E-02 | WS01/Omy04 | AGAGTAGA[C/T]CTCCAGGAACAGGTTAGGCCACCACTGACAAAGAACATCCAGCATTAGAG |
| R46597 | CWD | 3.99E-03 | 7.56E-02 | WS23/Omy17 | [C/T]GGTTTAGGACCTTTGTAATGACTTTCATTTAGCTAGCGCAAGTATTTGGTTCTGGGTT |
| R20199 | CWD | 4.03E-03 | 1.14E-01 | WS01/Omy04 | AAGGGTAACACATTTCCTGGGTTATTCAACTGGCCCCTCCGTCG[C/T]GACGTCCTCTGAAT |
| R53165 | CWD | 4.45E-03 | −2.64E-02 | WS04/Omy9 | TCTGTGACATCAACATGCTGTTTTCCTCAGTAGGGTCATGCAAAAACAAATG[T/G]CACCTT |
| R21407 | IHNV | 5.98E-05 | 5.24E-02 | WS13/Omy06 | GAGTGAGAATGGAGGACAAGAAGGTAGATG[G/C]GGTAAGGCCATGGCCAGTCCCAACCACC |
| IHNV | 9.52E-05 | −1.33E-01 | WS13/Omy06 | AGTACATAACATGAC[C/T]GTACATATTTAATATGCTATTCAAGTGTTTTAAGACACCAATA | |
| R24813 | IHNV | 8.95E-04 | 7.86E-02 | WS13/Omy06 | TTTGACTCCTGATGAATGCCCCGTCTGCGGAATCTCTCTTGCTCGCTCTCTC[A/G]GCAATC |
| R53135 | IHNV | 9.53E-04 | −1.23E-01 | NA | CACATTGCCTGGTGGCGTTTATTAATGTTTACATACTGTACCGTTT[A/C]TTTTTTTTTAAA |
| R03138 | IHNV | 1.01E-03 | 9.38E-03 | WS13/Omy06 | TGCCCGGCCCGCCACAAGGAGTCGCTTGA[A/G]CGAGTAAAGTCCCCCTGGTTGTGATACAG |
| R39227 | IHNV | 1.45E-03 | 1.49E-01 | WS07/Omy11 | C[C/A]TCCAGCTGCCTGCCTCACAGGCCAAATATGCTATTTAGAAAATTGGGATATAAGAGA |
| R53350 | IHNV | 1.63E-03 | −1.53E-02 | WS13/Omy06 | CCAAACTCTCCCCTAACCCGGACGACGCTGGGAAAATTGTA[C/T]GCCGCCCTATGGGTCTC |
| R52586 | IHNV | 1.66E-03 | 5.55E-02 | WS28/Omy26 | TAGACTGTAC[T/C]AAGAGCTGAATCACAACTCCTGTATGGATAACACCACACTGGTCAAGT |
| R46528 | IHNV | 1.78E-03 | −6.56E-02 | WS24/Omy25 | AGTGAGTCACTG[C/A]TTTGATGTTTGCAGAGCACGACAGAGTGTTGTGCAGGGTCATTGCA |
| R48860 | IHNV | 2.44E-03 | 1.37E-01 | WS14/Omy10 | CGCTCGCCC[T/C]GCCACAAGGAGTCGTTAGAACGCGATGAGCCAAGTAAAGCCCCCCAAGG |
| R33079 | IHNV | 2.46E-03 | −1.16E-02 | WS13/Omy06 | CCATGGGCAACCTCACCCCTCTCCATAC[C/G]CCTACTCCTCCACAGTCCCCTCAGAGCTCA |
| IHNV | 2.54E-03 | −6.30E-02 | WS13/Omy06 | GGACCCACCAATCCTGAAGAAGTTAAAGACTCCAGCCATTCAAGC[C/A]ATAGACTGGCTGG | |
| R19689 | IHNV | 3.29E-03 | 1.14E-01 | WS03/Omy05 | ATCATCTGAGACCAGCCACCCAGACAGCTGTGGGTTTGTGGGTTTGCACAACCAAATA[A/T] |
| R04597 | IHNV | 4.07E-03 | −7.38E-02 | WS03/Omy05 | CTCATCCTGACATGACCCTGCAGCTTGACAATGTCACCAGCCATACT[G/A]CTCGTTCTGAG |
| R14972 | IHNV | 4.19E-03 | 1.80E-02 | WS13/Omy06 | CTACCACTCTTTCCCCAAGTAAGTA[T/C]CCGGGTGAATGGTTAAACAACTAGCCTAAACAG |
| R18850 | IHNV | 4.19E-03 | −8.30E-02 | NA | TCTGGTGTCAGAATGCGCA[C/A]GGAGCTCCTCAGTGGATTACTTCTGGTACAGAGAGACAC |
| R45284 | IHNV | 4.37E-03 | 7.09E-02 | WS29/Omy13 | CTACTATTAAAGTATCACTGCTTTGGTGTGTAATTCCAAT[G/A]CCCCTTTATCTTTTAAGT |
| R05136 | IHNV | 4.87E-03 | −2.22E-02 | WS14/Omy10 | ACGGG[A/T]ATCACAATAGGGAGGAGGATGTCTTCCCTGTAATGCACAGTGTTAAGATTGCC |
| R52799 | IHNV | 5.16E-03 | −1.76E-01 | NA | GCTACAGACAGAC[T/G]ATCACTCTATCATGGTAGGATGGATGGAGGGAGGGAGCACATCAC |
Linkage group (LG) names are as reported by Miller et al. (2011)/Palti . The two bold and underlined loci align to the same contig in the O. mykiss draft genome. Marker sequences follow the SbfI recognition sequence “CCTGCAGG.” CWD, cold water disease; IHNV, infectious hematopoietic necrosis virus; RAD, restriction site−associated sequencing; BLUP, best linear unbiased predictor.
LG confirmed by alignment to Berthelot O. mykiss genome.
Directly matches mapped RAD locus from Miller et al. (2011).
LG assignment supported by Berthelot O. mykiss genomoe alignment only.
LG assignment confirmed by alignment to same draft genome contig as previously mapped RAD marker.
Figure 2Plots of significance values for each marker associated with resistance to each disease. (A) Bacterial cold water disease (CWD). (B) Infectious hematopoietic necrosis virus (IHNV). Horizontal lines in each figure represent increasingly stringent critical values where blue line is BY-FDR α = 0.05, and the red line is BY-FDR α = 0.01. Markers are ordered according to alignment to Berthelot genome position. Circles indicate a match to the properly scaffolded portion of each chromosome while triangles indicate a match to the unordered portion of the chromosome. An “x” indicates a match to the unknown chromosome and gray diamonds indicate that the marker was not found within the genome assembly.
Figure 1(A) Heat map of pairwise kinship among individuals included in the study. Red squares indicate an individual’s genetic relatedness to itself and orange blocks indicate genetically reconstructed family groups. (B) Principal coordinates plot of all individuals. Family groups are indicated by marker color/shape. PC, principal coordinate.
Figure 3Distribution of genetically evaluated breeding values (GEBVs) among disease challenged fish using significantly associated markers for (A) cold water disease (CWD) and (B) infectious hematopoietic necrosis virus (IHNV).